Inflammatory Bowel Disease (IBD) Panel – Diagnosing Chronic Digestive Disorders
The Inflammatory Bowel Disease (IBD) Panel includes a series of tests used to diagnose and monitor chronic inflammatory conditions of the digestive tract, such as Crohn’s disease and ulcerative colitis. These diseases cause inflammation in the gastrointestinal (GI) tract and can lead to symptoms such as abdominal pain, diarrhea, and weight loss.
Indications for IBD Panel:
● Chronic diarrhea or abdominal pain: Particularly when other causes have been ruled out.
● Blood in stool: May indicate inflammation in the intestines, often associated with ulcerative colitis or Crohn’s disease.
● Weight loss: Unexplained weight loss can occur in individuals with IBD due to malabsorption of nutrients.
● Family history: If there is a family history of IBD, regular screening may be recommended for early detection.
Methods to Diagnose IBD:
● Fecal Calprotectin Test: Measures the level of calprotectin in the stool, which is an indicator of intestinal inflammation.
● C-reactive Protein (CRP): Elevated CRP levels suggest active inflammation in the body, including the intestines.
● Anti-Saccharomyces cerevisiae antibodies (ASCA): A test to help differentiate between Crohn’s disease and other IBD forms.
● Perinuclear Anti-Neutrophil Cytoplasmic Antibodies (p-ANCA): Elevated p-ANCA levels are commonly seen in ulcerative colitis.
Normal Range:
● Fecal Calprotectin: Less than 50 µg/g.
● CRP: Less than 5 mg/L.
● ASCA: Negative (varies depending on laboratory).
Abnormal Test Significance:
● Elevated Fecal Calprotectin and CRP: Suggests active inflammation in the GI tract, often seen in IBD.
● Positive ASCA or p-ANCA: Helps distinguish between Crohn’s disease (ASCA positive) and ulcerative colitis(p-ANCA positive).
Management Based on Results:
● For Crohn’s disease: Treatment may involve anti-inflammatory medications like mesalamine or biologic therapies such as infliximab.
● For ulcerative colitis: Treatment can include steroids, immunosuppressive drugs, or surgical intervention in severe cases.
Price in India:
● Approx. ₹3,000 – ₹7,000 for the IBD panel.
FAQs
What causes inflammatory bowel disease?
IBD is caused by an abnormal immune response that leads to inflammation in the GI tract.
How is IBD managed?
Management includes anti-inflammatory drugs, biologic therapies, and dietary modifications, with surgery sometimes required.
Disclaimer:
IBD diagnosis should be confirmed by a combination of clinical symptoms, laboratory tests, and imaging studies. Treatment should be managed by a gastroenterologist.
How HealthPil Can Help:
At HealthPil, we offer access to gastroenterologists who can interpret your IBD test results, recommend appropriate treatments, and guide you in managing your symptoms effectively.
